PMID- 30341657 OWN - NLM STAT- MEDLINE DCOM- 20200430 LR - 20200430 IS - 1432-2218 (Electronic) IS - 0930-2794 (Linking) VI - 33 IP - 8 DP - 2019 Aug TI - Effect of revisional bariatric surgery on type 2 diabetes mellitus. PG - 2642-2648 LID - 10.1007/s00464-018-6541-1 [doi] AB - INTRODUCTION: Bariatric and metabolic surgery significantly improves type 2 diabetes mellitus (T2DM). However, a small percentage of patients after bariatric surgery either have persistent hyperglycemia or relapse of their T2DM. These patients are usually medically managed. The aim of this study was to evaluate the effect of revisional surgery on the glycemic status of patients with T2DM who either failed to remit or relapsed after an initial remission following bariatric surgery. METHODS: Metabolic parameters and clinical outcomes of 81 patients with persistent or relapsed T2DM after revisional bariatric surgery at an academic center between 2008 and 2017 were studied. RESULTS: The most common types of revisional surgery were pouch and/or stoma revision of Roux-en-Y gastric bypass (RYGB) (n = 22, 27.2%), conversion of vertical banded gastroplasty (VBG) to RYGB (n = 20, 24.7%), conversion of adjustable gastric banding (AGB) to RYGB (n = 14, 17.3%), and conversion of sleeve gastrectomy (SG) to RYGB (n = 13, 16%). Revision of pouch/stoma after RYGB yielded improvement of T2DM in 50% of patients and remission in 22.7%. Conversion to RYGB yielded improvement of T2DM in 55%, 35.7%, and 30.8% of patients who previously had VBG, AGB, or SG, respectively. Furthermore, conversion of VBG, AGB, and SG to RYGB was associated with diabetes remission rates of 35%, 35.7%, and 23.1%, respectively. CONCLUSION: Findings of this study, which is the largest series to date, indicate that revisional surgery in patients with persistent or relapsed T2DM after bariatric surgery can significantly improve glucose control and use of diabetes medications. Further clinical and mechanistic studies are needed to better demonstrate the role of revisional bariatric surgery in patients with residual T2DM. FAU - Aleassa, Essa M AU - Aleassa EM AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. AD - Department of Surgery, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. FAU - Hassan, Monique AU - Hassan M AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. FAU - Hayes, Kellen AU - Hayes K AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. FAU - Brethauer, Stacy A AU - Brethauer SA AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. FAU - Schauer, Philip R AU - Schauer PR AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. FAU - Aminian, Ali AU - Aminian A AD - Department of General Surgery, Bariatric and Metabolic Institute, Cleveland Clinic, 9500 Euclid Ave, M61, Cleveland, OH, 44195, USA. aminiaa@ccf.org. LA - eng PT - Journal Article DEP - 20181019 PL - Germany TA - Surg Endosc JT - Surgical endoscopy JID - 8806653 RN - 0 (Blood Glucose) RN - 0 (Hypoglycemic Agents) SB - IM MH - Adult MH - *Bariatric Surgery MH - Blood Glucose/metabolism MH - Diabetes Mellitus, Type 2/blood/*complications/*drug therapy MH - Female MH - Gastrectomy MH - Gastric Bypass MH - Gastroplasty MH - Humans MH - Hypoglycemic Agents/therapeutic use MH - Male MH - Middle Aged MH - Obesity, Morbid/*complications/*surgery MH - *Reoperation MH - Retrospective Studies MH - Surgical Stomas MH - Weight Loss OTO - NOTNLM OT - Adjustable gastric banding OT - Diabetes OT - Revisional bariatric surgery OT - Roux-en-Y gastric bypass OT - Sleeve gastrectomy OT - Vertical band gastroplasty EDAT- 2018/10/21 06:00 MHDA- 2020/05/01 06:00 CRDT- 2018/10/21 06:00 PHST- 2018/04/17 00:00 [received] PHST- 2018/10/15 00:00 [accepted] PHST- 2018/10/21 06:00 [pubmed] PHST- 2020/05/01 06:00 [medline] PHST- 2018/10/21 06:00 [entrez] AID - 10.1007/s00464-018-6541-1 [pii] AID - 10.1007/s00464-018-6541-1 [doi] PST - ppublish SO - Surg Endosc. 2019 Aug;33(8):2642-2648. doi: 10.1007/s00464-018-6541-1. Epub 2018 Oct 19.